SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 30, 2003 (April 30, 2003)
ENDO PHARMACEUTICALS HOLDINGS INC.
(Exact name of registrant as specified in its charter)
| | | | | |
DELAWARE
(State or other
jurisdiction of
incorporation)
| | 39040
(Commission File Number) | | 13-4022871
(I.R.S. Employer
Identification No.) |
100 Painters Drive
Chadds Ford, Pennsylvania
(Address of principal executive offices) | | | | 19317
(Zip Code) |
(610) 558-9800
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits.
| (a) | | Financial Statements of Business Acquired. |
| |
| | | Not applicable. |
| |
| (b) | | Pro Forma Financial Information. |
| |
| | | Not applicable. |
| |
| (c) | | Exhibits. |
| | | |
Exhibit No.
| | Description
|
| 99.1 | | Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated April 30, 2003 |
Item 9. Regulation FD Disclosure.
On April 30, 2003, the Registrant intends to make a slide presentation at the CIBC Annual Biotechnology and Specialty Pharmaceuticals Conference in New York, New York, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | | | |
| | | | | ENDO PHARMACEUTICALS HOLDINGS INC.
(Registrant) |
| |
| | | | | |
| |
| | | | | By: /s/ CAROL A. AMMON
Name: Carol A. Ammon
Title: Chairman & Chief Executive Officer |
| |
| Dated: | | April 30, 2003 | | |
INDEX TO EXHIBITS
| | | |
Exhibit No.
| | Description
|
| 99.1 | | Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated April 30, 2003 |
